Today’s PCMA PBM “Policy Forum”: A Parallel Universe of Propaganda and Puffery
New Kaiser Health Tracking Poll Finds More Bad News for Nation’s Beleaguered PBMs as Majorities of Democrats, Republicans, Independents Want Action on Drug Pricing
Washington, DC — With the Pharmaceutical Care Management Association (PCMA) today holding its 2017 “PBM Policy Forum” at the Newseum, the Senior Care Pharmacy Coalition (SCPC) said the gathering and its discussion is yet another attempt to divert attention away from the fact that pharmacy benefit managers (PBMs) are part of the problem when it comes to skyrocketing pharmaceutical prices.
“It’s ironic PCMA is holding its forum at the Newseum as all of the ‘news’ being reported about PBMs is overwhelmingly negative,” said Alan G. Rosenbloom, President and CEO of the SCPC. “The PCMA ‘policy forum’ is a parallel universe of PBM propaganda and puffery that flies in the face of reality as a growing bipartisan coalition of lawmakers demand more accountable, transparent PBM drug pricing practices.”
Rosenbloom said health insurer Anthem’s likely dumping of its PBM, Express Scripts — due to overcharging — represents the “biggest news surrounding dishonest, disingenuous, deceptive PBM pricing practices thus far in 2017” and predicted that by year end, “the story will be just the tip of the iceberg.”
A new Kaiser Health tracking poll finds lowering the cost of prescription drugs continues to rise as an important public concern: Six in ten Americans say lowering the cost of prescription drugs should be a ‘top priority’ for President Trump and Congress – including majorities of Democrats, Republicans, and independents.”
Rosenbloom said Congress’s growing scrutiny of PBM pricing practices will continue to escalate as the public becomes increasingly angry about the lack of PBM transparency and “the brazen manner in which the middlemen cling to the fiction they are benevolent, pro-consumer actors in the drug pricing debate.”
Concluded Rosenbloom: “PBMs are attempting to perpetuate a secretive, opaque drug pricing game that may have worked to their advantage ten years ago — when there was less attention focused on their surreptitious activities. But that is not sustainable nor realistic in 2017 as the entirety of the drug pricing chain is rightly subject to vastly more consumer and governmental accountability.”
###
The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities in across the country occupying approximately 675,000 beds across the country. Visit us at www.seniorcarepharmacies.org to learn more.
Recent Posts
-
NCPA Advocates for Medicare Drug Price Negotiation Program Overhaul Due to Pharmacy Cash Flow
With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.
The National Community Pharmacists Association (NCPA) is sounding the alarm over the federal government’s implementation of the Medicare Drug Price Negotiation Program (MDPNP) after a recent survey of its members revealed significant financial distress, according to a news release.
-
Pharmacies To Face Low Cash Flow For MFP Drugs Until Fixes Emerge
A bill introduced last year aiming to ensure long-term care (LTC) pharmacies can continue to supply and dispense Medicare Part D drugs despite lower prices resulting from the price negotiation program will need to be tweaked to ensure the intended relief is retroactive, according to Alan Rosenbloom, executive director of the Senior Care Pharmacy Coalition (SCPC).
-
SCPC Applauds Inclusion of PBM Reform in Recent Spending Package Approved by U.S. House & Senate
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement about the passage of PBM reform: “SCPC applauds the passage of bipartisan pharmacy benefit manager (PBM) reform legislation by both the U.S. House and Senate, marking a significant step toward greater transparency, accountability, and fairness in the prescription drug marketplace. These […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.